Nervgen Pharma NGEN
NASDAQ NGEN
$1.44 +0.02 (+1.41%)
As of: Oct 23, 2026 · 2:52 PM EDT

Nervgen Pharma (NGEN) Cash & Equivalents (2024 - 2026)

Updated

Nervgen Pharma's Cash & Equivalents was $62.74 million in the quarter ended Jun 30, 2026, up 419.6% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Cash & Equivalents (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Cash & Equivalents at Nervgen Pharma came in at $15.8 million, up 25.2% from the prior year.

  • In earlier years, Cash & Equivalents was $12.61 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,127.89 Bn 1,096.47 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.11 Bn 554.97 Bn 17.30 Bn 16.91 Bn
3 AbbVie 504.69 Bn 477.80 Bn 12.70 Bn 6.57 Bn
4 Merck 358.24 Bn 312.62 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 290.13 Bn 254.12 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.87 Bn 193.27 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.91 Bn 169.11 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn 976.00 Mn
10 Nervgen Pharma 104.16 Mn 3.04 Mn - 61.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 61.08 Mn
Mar 31, 2026 11.89 Mn
Dec 31, 2025 16.12 Mn
Dec 31, 2024 12.03 Mn
API Access

Nervgen Pharma Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NGEN&period=max&api_key=YOUR_API_KEY